About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.
Vision: A world without type 1 diabetes
Mission: Accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications
Type 1 diabetes is an autoimmune disease that strikes both children and adults suddenly. It has nothing to do with diet or lifestyle. There is nothing you can do to prevent it. And, at present, there is no cure.
In T1D, your pancreas stops producing insulin—a hormone the body needs to get energy from food. This means a process your body does naturally and automatically becomes something that now requires your daily attention and manual intervention. If you have T1D, you must constantly monitor your blood-sugar level, inject or infuse insulin through a pump, and carefully balance these insulin doses with your eating and activity throughout the day and night.
However, insulin is not a cure for diabetes. Even with the most vigilant disease management, a significant portion of your day will be spent with either high or low blood-sugar levels. These fluctuations place people with T1D at risk for potentially life-threatening hypoglycemic and hyperglycemic episodes as well as devastating long-term complications such as kidney failure, heart attack, stroke, blindness and amputation. Learn more about T1D.
JDRF works every day to change the reality of this disease for millions of people—and to prevent anyone else from ever knowing it—by funding research, advocating for government support of research and new therapies, ensuring new therapies come to market
and connecting and engaging the T1D community. Founded by parents determined to find a cure for their children with T1D, JDRF expanded through grassroots fundraising and advocacy efforts to become a powerhouse in the scientific community with more
than 100 U.S. locations and six international affiliates. We’ve funded nearly $2 billion in research to date and made significant progress in understanding and fighting the disease. We must keep up the pace of funding so progress doesn’t slow or
stop entirely.
We have some of the best ratings for an organization focused on a single
disease from charity watchdog groups and media. In 2012, Forbes named JDRF one of its five “All-Star” charities, based on its evaluation of our financial efficiency.
Visit Our Website